[Re-allign (randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran ftexilate in patients after heart valve replacement)]. [electronic resource]
Producer: 20150522Description: 1108-9, 1111 p. digitalISSN:- 1432-1289
- Administration, Oral
- Adolescent
- Adult
- Aged
- Antithrombins -- administration & dosage
- Benzimidazoles -- administration & dosage
- Dabigatran
- Female
- Heart Valve Prosthesis Implantation -- adverse effects
- Humans
- Male
- Metabolic Clearance Rate
- Middle Aged
- Thrombosis -- etiology
- Tissue Distribution
- Treatment Outcome
- Young Adult
- beta-Alanine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.